Unified Patent Court (UPC) analytics are now available. Check here

Law FirmOpposition Filing Analysis

The comprehensive analysis of Wichmann opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Wichmann

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3529360Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionTHE MEDICINESJan 15, 2025ZAKLADY FARMACEUTYCZNE POLPHARMA
EP3227447Guide Rna With Chemical ModificationsAGILENTJan 14, 2025WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP3226887Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasACCELERON PHARMADec 20, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP3460063Methods And Compositions For The Targeted Modification Of A GenomeREGENERON PHARMACEUTICALSDec 12, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP3380121Methods For Treating Eye DisordersACCELERON PHARMASep 18, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
EP3384049Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VegfREGENERON PHARMACEUTICALSApr 24, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP3450562Method For Producing 2'-Fucosyllactose By Using Corynebacterium GlutamicumSEOUL NATIONAL UNIVERSITY R&DB FOUNDATIONApr 16, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP2967015Transgenic Mice Expressing Chimeric Major Histocompatibility Complex (Mhc) Class Ii MoleculesREGENERON PHARMACEUTICALSMar 5, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
EP3363811Method For Producing Fusion Protein Having Igg Fc DomainALTEOGENJan 17, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
EP3575792Method Of Assessing Risk Of PmlBIOGEN MAAug 30, 2023SANDOZ